[Sentinel nodes identification efficacy prognostic criteria in breast cancer] (2005)

Peer-Reviewed Study · Kokhreidze ID, Nemsadze GG, Gersamiia GK, Dzagnidze GB, Dzhandzhaliia MT · February 2005

Kokhreidze ID et al., 2005-02: Post-Soviet Georgian series of 99 breast-cancer patients in which methylene blue injection was used for sentinel-node identification; identification rate 69.7% and false-negative rate 7.1%.

The sentinel lymph node biopsy with total axillary dissection was performed on 99 patients.

31-4

Kokhreidze ID et al., 2005-02: Post-Soviet Georgian series of 99 breast-cancer patients in which methylene blue injection was used for sentinel-node identification; identification rate 69.7% and false-negative rate 7.1%. C1 (Russian-language publication sphere; country Georgia). Study type: prospective/observational surgical series, N=99. Methylene blue injected (method of injection studied as a prognostic factor); exact dose/concentration not in abstract. Comparator: total axillary dissection as reference standard. Funder/conflicts: none declared in record. Journal published in Russian with English abstract; record language 'rus'. Note the modest 69.7% identification rate.